Donepezil hydrochloride
- Product NDC
- 55111-302
- 11-digit product format
- 551110302
- Labeler code
- 55111
- Product ID
- 55111-302_0df6bfb2-4604-2035-9677-06c125e77bb9
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Donepezil hydrochloride
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Dr. Reddys Laboratories Limited
- Application
- ANDA202723
- Marketing category
- ANDA
- Marketing start
- 2025-08-20
- Substance
- DONEPEZIL HYDROCHLORIDE
- Active strength
- 23 mg/1
- Pharmacologic classes
- Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Donepezil hydrochloride
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| DONEPEZIL HYDROCHLORIDE | 23 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 3O2T2PJ89D |
| Rxcui | 1100184 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
NDC, Effective, Action table| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|
| 55111-302-05 | 2025-03-04 | C162847 | 48780-1 | 2cef2736-96a5-d83d-e063-dadaa90ab31f | These highlights do not include all the information needed to use DONEPEZIL HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for DONEPEZIL HYDROCHLORIDE TABLETS. DONEPEZIL HYDROCHLORIDE tablets, for oral use Initial U.S. Approval: 1996 |
| 55111-302-10 | 2025-03-04 | C162847 | 48780-1 | 2cef2736-96a5-d83d-e063-dadaa90ab31f | These highlights do not include all the information needed to use DONEPEZIL HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for DONEPEZIL HYDROCHLORIDE TABLETS. DONEPEZIL HYDROCHLORIDE tablets, for oral use Initial U.S. Approval: 1996 |
| 55111-302-30 | 2025-03-04 | C162847 | 48780-1 | 2cef2736-96a5-d83d-e063-dadaa90ab31f | These highlights do not include all the information needed to use DONEPEZIL HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for DONEPEZIL HYDROCHLORIDE TABLETS. DONEPEZIL HYDROCHLORIDE tablets, for oral use Initial U.S. Approval: 1996 |
| 55111-302-90 | 2025-03-04 | C162847 | 48780-1 | 2cef2736-96a5-d83d-e063-dadaa90ab31f | These highlights do not include all the information needed to use DONEPEZIL HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for DONEPEZIL HYDROCHLORIDE TABLETS. DONEPEZIL HYDROCHLORIDE tablets, for oral use Initial U.S. Approval: 1996 |
| 55111-302-05 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-96a5-d83d-e063-dadaa90ab31f | These highlights do not include all the information needed to use DONEPEZIL HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for DONEPEZIL HYDROCHLORIDE TABLETS. DONEPEZIL HYDROCHLORIDE tablets, for oral use Initial U.S. Approval: 1996 |
| 55111-302-10 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-96a5-d83d-e063-dadaa90ab31f | These highlights do not include all the information needed to use DONEPEZIL HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for DONEPEZIL HYDROCHLORIDE TABLETS. DONEPEZIL HYDROCHLORIDE tablets, for oral use Initial U.S. Approval: 1996 |
| 55111-302-30 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-96a5-d83d-e063-dadaa90ab31f | These highlights do not include all the information needed to use DONEPEZIL HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for DONEPEZIL HYDROCHLORIDE TABLETS. DONEPEZIL HYDROCHLORIDE tablets, for oral use Initial U.S. Approval: 1996 |
| 55111-302-90 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-96a5-d83d-e063-dadaa90ab31f | These highlights do not include all the information needed to use DONEPEZIL HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for DONEPEZIL HYDROCHLORIDE TABLETS. DONEPEZIL HYDROCHLORIDE tablets, for oral use Initial U.S. Approval: 1996 |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 55111-302-30 | Donepezil hydrochloride | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | | 10 |
| 55111-302-90 | Donepezil hydrochloride | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | | 10 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| DONEPEZIL HYDROCHLORIDE | ACTIVE INGREDIENT | 3O2T2PJ89D | DONEPEZIL HYDROCHLORIDE TABLET, FILM COATED [DR. REDDYS LABORATORIES LIMITED] | 3 | |
| Donepezil | ACTIVE MOIETY | 8SSC91326P | DONEPEZIL HYDROCHLORIDE TABLET, FILM COATED [DR. REDDYS LABORATORIES LIMITED] | 3 | |
| FERRIC OXIDE RED | INACTIVE INGREDIENT | 1K09F3G675 | DONEPEZIL HYDROCHLORIDE TABLET, FILM COATED [DR. REDDYS LABORATORIES LIMITED] | 3 | |
| FERRIC OXIDE YELLOW | INACTIVE INGREDIENT | EX438O2MRT | DONEPEZIL HYDROCHLORIDE TABLET, FILM COATED [DR. REDDYS LABORATORIES LIMITED] | 3 | |
| HYDROXYPROPYL CELLULOSE | INACTIVE INGREDIENT | RFW2ET671P | DONEPEZIL HYDROCHLORIDE TABLET, FILM COATED [DR. REDDYS LABORATORIES LIMITED] | 3 | |
| HYPROMELLOSE 2208 (100 MPA.S) | INACTIVE INGREDIENT | B1QE5P712K | DONEPEZIL HYDROCHLORIDE TABLET, FILM COATED [DR. REDDYS LABORATORIES LIMITED] | 3 | |
| lactose monohydrate | INACTIVE INGREDIENT | EWQ57Q8I5X | DONEPEZIL HYDROCHLORIDE TABLET, FILM COATED [DR. REDDYS LABORATORIES LIMITED] | 3 | |
| magnesium stearate | INACTIVE INGREDIENT | 70097M6I30 | DONEPEZIL HYDROCHLORIDE TABLET, FILM COATED [DR. REDDYS LABORATORIES LIMITED] | 3 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1) | INACTIVE INGREDIENT | 74G4R6TH13 | DONEPEZIL HYDROCHLORIDE TABLET, FILM COATED [DR. REDDYS LABORATORIES LIMITED] | 3 | |
| POLYETHYLENE GLYCOLS | INACTIVE INGREDIENT | 3WJQ0SDW1A | DONEPEZIL HYDROCHLORIDE TABLET, FILM COATED [DR. REDDYS LABORATORIES LIMITED] | 3 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | DONEPEZIL HYDROCHLORIDE TABLET, FILM COATED [DR. REDDYS LABORATORIES LIMITED] | 3 | |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 55111-302-05 | 55111030205 | 500 TABLET, FILM COATED in 1 BOTTLE (55111-302-05) | 2013-07-26 | 0000-00-00 | No | No | Current |
| 55111-302-10 | 55111030210 | 1000 TABLET, FILM COATED in 1 BOTTLE (55111-302-10) | 2013-07-26 | 0000-00-00 | No | No | Current |
| 55111-302-30 | 55111030230 | 30 TABLET, FILM COATED in 1 BOTTLE (55111-302-30) | 2025-08-20 | 0000-00-00 | No | No | Current |
| 55111-302-90 | 55111030290 | 90 TABLET, FILM COATED in 1 BOTTLE (55111-302-90) | 2025-08-20 | 0000-00-00 | No | No | Current |